Fatigue after treatment for early stage breast cancer: A controlled comparison

Cancer

Volumn 110, Issue 8, 2007, Pages 1851-1859

  Jacobsen, Paul B ^a   Donovan, Kristine A ^b   Small, Brent J ^a,b   Jim, Heather S ^b   Munster, Pamela N ^a   Andrykowski, Michael A ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adjuvant therapy; Breast cancer; Fatigue; Survivorship

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAXANE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; UNITED STATES;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FATIGUE; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS;

EID: 35048840411     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22993     Document Type: Article

References (31)

1. Andrykowski MA, Cordova MJ, Hann DH, Jacobsen PB, Fields KK, Phillips G. Patients' psychosocial concerns following stem cell transplantation. Bone Marrow Transplant. 1999;24:1121-1129.
2. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104:2565-2576.
3. Fox SW, Lyon DE. Symptom clusters and quality of life in survivors of lung cancer. Oncol Nurs Forum. 2006;33:931-936.
4. Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45:53-65.
5. Watt T, Groenvold M, Bjorner JB, Noerholm V, Rasmussen NA, Bech P. Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Community Health. 2000;54:827-833.
6. Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primary-care study. Psychol Med. 1995;25:895-906.
7. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106:751-758.
8. Donovan KA, Jacobsen PB, Andrykowski MA, et al. Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage. 2004;28:373-380.
9. Hwang SS, Chang VT, Rue M, Kasimis B. Multiple independent predictors of cancer-related fatigue. J Pain Symptom Manage. 2003;26:604-614.
10. Andrykowski MA, Curran SL, Lightner R. Off treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med. 1998;21:1-18.
11. Broeckel JA, Jacobsen PB, Horton JH, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16:1689-1696.
12. Hann DH, Jacobsen P, Azzarello L, Greenberg H. Fatigue and quality of life following radiotherapy for breast cancer: a comparative study. J Clin Psychol Med Settings. 1998;5:19-33.
13. Robb C, Haley WE, Balducci L, et al. Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol/Hematol. 2007;62:84-91.
14. Tomich PL, Helgeson VS. Five years later: a cross-sectional comparison of breast cancer survivors with healthy women. Psychooncology. 2002;11:154-169.
15. Talbott EO, Norman SA, Baffone KM, et al. Selection of neighborhood controls for a study of factors related to the diagnosis of cervical cancer. J Clin Epidemiol. 1993;46:1277-1287.
16. Helgeson VS, Tomich PL. Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology. 2005;14:307-317.
17. Helgeson VS, Cohen S, Schulz R, Yasko J. Educational and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry. 1999;56:340-347.
18. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18:743-753.
19. Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum. 1998;25:915-920.
20. Hann DH, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998;7:301-310.
21. McNair DM, Lorr M, Droppleman L. Profile of Mood States Manual. San Diego: Educational and Industrial Testing Service; 1971.
22. Taylor MJ, Heaton RK. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factors scores in neuropsychological assessment. J Int Neuropsychol Soc. 2001;7:867-874.
23. Schafer JL. Analysis of incomplete multivariate data. New York: Chapman and Hall; 1997.
24. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531-1548.
25. Wilson IB. Clinical understanding and clinical implications of response shift. Soc Sci Med. 1999;48:1577-1588.
26. Jansen SJ, Stiggelbout AM, Nooij MA, Noordijk EM, Kievit J. Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. Qual Life Res. 2000;9:603-615.
27. Visser MR, Smets EM, Sprangers MA, de Haes HJ. How response shift may affect the measurement of change in fatigue. J Pain Symptom Manage. 2000;20:12-18.
28. Donovan KA, Small BJ, Andrykowski MA, Munster P, Jacobsen PB. Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol. 2007;26:464-472.
29. Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21:1660-1668.
30. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002;64:604-611.
31. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006;12:2759-2766.